NicolePCanada

I meant a Canadian thing to not do it.

@AuntiS Must be a Canadian thing.

We stopped doing LUI freeze eluates a very long time ago. If Mom has no clinically significant antibodies and there is an ABO incompatibility between Mom and infant, it is pretty clear the cause of the Positive DAT on the baby. There will be no difference in the treatment of the baby if we did the LUI freeze. Our report goes out as Possible ABO incompatibility, no further testing indicated. Regardless, in Canada we don't bill anything, it is covered by our healthcare benefits. My point is that other than a way to bill the patient, it isn't a clinically significant test.

Our DTT procedure is send it to a reference lab. I can't help out with this one. Sorry.

Hello cthherbal, We are about to Go Live with Cerner Millenium. So for the reports, to me, look like **** for what I need to report out monthly to Canadian Blood services. What reports are you running to manually extract this data? Thanks, Nikki

This doesn't necessarily speak to your topic of how to get them to order irradiated properly or how to make sure the techs notice it, but I attached the link to the National Advisory Committee Guidelines for when Irradiated blood is required. This is Canadian, but interesting information, none the less. https://www.nacblood.ca/resources/guidelines/downloads/Recommendations_Irradiated_Blood_Components.pdf

I'm signed up and I can't wait. We are implementing electronic issue in April of 2021. Malcolm you rock!

Since we opened this topic back up........I was simply going to stop using LISS rather than validating a new type. We never use it anyway. If we can't solve it we send it to Canadian Blood Services. Is there a good reason why we should keep it? Malcolm?

Malcolm Needs, You do not disappoint. As soon as I saw this post re-emerge, I was just going to log in and answer for you. I tell so many people there is no place in the Blood Bank for a microscope. I love Issit's comment that "it causes more problems than it solves". Thanks for your sharing of knowledge.

If we only do D typing on babies from D negative mothers and a weak D or Du test needs to be performed, the results of the weak D is only valid if the DAT is negative, so a DAT would need to be performed. Therefore, an ABO and DAT would be a good place to start. Just my thought.

We use Immucor for our reverse (back) type and the package insert indicates that we need to confirm the reactivity of the A1, A2, and B red blood cells, not the negative results. So, we only daily QC that they are reactive.

https://www.nacblood.ca/resources/guidelines/CMV.html These are the Canadian National Advisory Committee Guidelines for use of CMV Negative Blood Products.

No Ensis, I'm only asking if there is a specific time between the drawing of the sample and the date of injection mentioned in any standards anywhere. Historically, we have always said it had to be 14 days between sample draw and injection. I'm just wondering if there was a reason. Thanks for your response.

Thank you Mabel. I understand the why of RhIg. I just wasn't sure if 30 days was an acceptable amount of time to have the sample for or if there was a worry of other antibody formation between the time of draw and the time of injection. Perhaps I am just not explaining myself well enough. Thanks for your response.

Does anybody know if there is documentation or requirements anywhere indicating the length of time a sample is good for on an Rh Negative pregnant woman who requires her 28 week RHIG injection? We have always said the injection must be within 14 days, but as with many other things, I'm not sure if there is a scientific reason for this or if it is one of those "That's the way it's always been things" Thanks for your time